期刊文献+

Anti TB drug resistance in Tanga,Tanzania:a cross sectional facility base prevalence among pulmonary TB patients

Anti TB drug resistance in Tanga,Tanzania:a cross sectional facility base prevalence among pulmonary TB patients
下载PDF
导出
摘要 Objective:To determine the prevalence and risk factors associated with drug resistance tuberculosis(TB) at facility-base level in Tanga,Tanzania.Methods:A total of 79 Mycobacterium tuberculosis(MTB) isolates included in the study were collected from among372(312 new and 60 previously treated) TB suspects self referred to four TB clinics during a prospective study conducted from November 2012 to January 2013.Culture and drug susceptibility test of the isolates was performed at the institute of medical microbiology and epidemiology of infectious diseases,University hospital,Leipzig,Germany.Data on the patient's characteristics were obtained from structured questionnaire administered to the patients who gave informed verbal consent.Unadjusted bivariate logistic regression analysis was performed to assess the risk factors for drug resistant-TB.The significance level was determined at P<0.05.Results:The overall proportions of any drug resistance and MDRTB were 12.7%and 6.3%respectively.The prevalence of any drug resistance and MDRTB among new cases were 11.4%and 4.3%respectively,whereas among previously treated cases was 22.2%respectively.Previously treated patients were more likely to develop anti-TB drug resistance.There was no association between anti-TB drug resistances(including MDRTB) with the risk factors analysed.Conclusions:High proportions of anti TB drug resistance among new and previously treated cases observed in this study suggest that,additional efforts still need to be done in identifying individual cases at facility base level for improved TB control programmes and drug resistance survey should continuously be monitored in the country. Objective:To determine the prevalence and risk factors associated with drug resistance tuberculosis(TB) at facility-base level in Tanga,Tanzania.Methods:A total of 79 Mycobacterium tuberculosis(MTB) isolates included in the study were collected from among372(312 new and 60 previously treated) TB suspects self referred to four TB clinics during a prospective study conducted from November 2012 to January 2013.Culture and drug susceptibility test of the isolates was performed at the institute of medical microbiology and epidemiology of infectious diseases,University hospital,Leipzig,Germany.Data on the patient’s characteristics were obtained from structured questionnaire administered to the patients who gave informed verbal consent.Unadjusted bivariate logistic regression analysis was performed to assess the risk factors for drug resistant-TB.The significance level was determined at P<0.05.Results:The overall proportions of any drug resistance and MDRTB were 12.7%and 6.3%respectively.The prevalence of any drug resistance and MDRTB among new cases were 11.4%and 4.3%respectively,whereas among previously treated cases was 22.2%respectively.Previously treated patients were more likely to develop anti-TB drug resistance.There was no association between anti-TB drug resistances(including MDRTB) with the risk factors analysed.Conclusions:High proportions of anti TB drug resistance among new and previously treated cases observed in this study suggest that,additional efforts still need to be done in identifying individual cases at facility base level for improved TB control programmes and drug resistance survey should continuously be monitored in the country.
出处 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2015年第11期887-893,共7页 亚太热带医药杂志(英文版)
基金 financial support from the GermanyAcademic Exchange Service(DAAD)
关键词 PULMONARY TUBERCULOSIS PREVALENCE Drug resistance Pulmonary tuberculosis Prevalence Drug resistance
  • 相关文献

参考文献13

  • 1Christopher Fitzpatrick,Katherine Floyd.A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis[J]. PharmacoEconomics . 2012 (1)
  • 2Comparison of Mycobacterium tuberculosis susceptibility testing performed with BACTEC 460TB (Becton Dickinson) and MB/BacT (Organon Teknika) systems[J]. Diagnostic Microbiology & Infectious Disease . 2000 (2)
  • 3C.S.B. Lambregts-van Weezenbeek,J. Veen.Control of drug-resistant tuberculosis[J]. Tubercle and Lung Disease . 1995 (5)
  • 4Aktas E,Durmaz R,Yang D,Yang Z.Molecular characterization of isoniazid and rifampin resistance of Mycobacterium tuberculosis clinical isolates from Malatya. http://online.liebertpub.com/ doi/abs/10.1089/mdr.2005.11.941 . 2014
  • 5Ranganath R,Kumar GSV,Javali V,Ranganadi R.Line probe assay as a rapid tool for detection of MDRTB. Ann Res Rer Biol . 2014
  • 6WHO.Interim recommendations for the surveillance of drug resistance in tuberculosis. . 2007
  • 7WHO.Guidelines for surveillance of drug resistance in tuberculosis. . 2009
  • 8Beer J,K (u|¨)chler R,Rodloff AC.Investigations about the possibility for testing the susceptibility of mycobacteria with the MB/BacT culture system. Laboratoriums Medizin . 1997
  • 9Kent PT,Kubica GP.Public health mycobacteriology:a guide fur the levelⅢlaboratory. . 1985
  • 10NTLP.Manual of the national tuberculosis and leprosy programme in Tanzania. . 2006

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部